CRISPR Therapy and Genetic Disorders Recent studies and clinical trials show that NTLA-2001 successfully reduced TTR proteins, considered responsible for ATTR (transthyretin amyloidosis). The NTLA-2001 was… July 26, 2021 · by Asheley Rice · 0
